Table 2.
Prognostic Value of ALDOA Expression Levels for the Biochemical Recurrence-Free Survival of PCa Patients on Univariate and Multivariate Analyses by Cox Regression Analyses
Univariable Analysis | Multivariable Analysis | |||
---|---|---|---|---|
HR (95% CI) | P | HR (95% CI) | P | |
Preoperative serum PSA (≥4 vs <4) | 1.311 (0.508–3.381) | 0.576 | 0.816 (0.304–2.191) | 0.964 |
Gleason score (≥8 vs <8) | 11.540 (5.810–22.921) | 0.000 | 7.367 (3.491–15.547) | 0.000 |
Pathological tumor stage (≥T3A vs <T3A) | 5.221 (2.559–10.655) | 0.000 | 2.935 (1.341–6.424) | 0.007 |
ALDOA (high vs low) | 2.288 (1.143–4.581) | 0.019 | 1.886 (0.905–3.933) | 0.090 |
Abbreviations: HR, hazard ratio; CI, confidence interval.